Universal Ibogaine Inc. (IBOGF)
USD 0.02
(-11.05%)
USD 0.02
(-11.05%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2022 | -0.06 CAD | -82.85% |
| 2021 | -0.03 CAD | -209.0% |
| 2020 | -0.01 CAD | 0.0% |
| 2019 | -0.01 CAD | 75.0% |
| 2018 | -0.04 CAD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 Q2 | -0.00 CAD | 6.82% |
| 2023 Q1 | -0.00 CAD | 0.0% |
| 2023 Q3 | -0.00 CAD | 39.02% |
| 2022 Q4 | - CAD | 100.0% |
| 2022 FY | - CAD | -82.85% |
| 2022 Q3 | -0.01 CAD | -12.73% |
| 2022 Q2 | -0.01 CAD | 46.08% |
| 2022 Q1 | -0.01 CAD | -385.71% |
| 2021 Q3 | - CAD | 100.0% |
| 2021 FY | - CAD | -209.0% |
| 2021 Q1 | -0.01 CAD | -27.66% |
| 2021 Q4 | -0.00 CAD | 0.0% |
| 2021 Q2 | -0.01 CAD | -66.67% |
| 2020 Q1 | -0.00 CAD | -3.7% |
| 2020 Q2 | -0.00 CAD | 28.57% |
| 2020 Q4 | -0.00 CAD | 0.0% |
| 2020 FY | - CAD | 0.0% |
| 2020 Q3 | - CAD | 100.0% |
| 2019 Q3 | - CAD | 100.0% |
| 2019 FY | - CAD | 75.0% |
| 2019 Q4 | -0.00 CAD | 0.0% |
| 2019 Q2 | -0.00 CAD | -47.06% |
| 2019 Q1 | -0.00 CAD | 45.16% |
| 2018 Q2 | -0.01 CAD | 50.0% |
| 2018 Q1 | -0.02 CAD | -100.0% |
| 2018 Q3 | - CAD | 100.0% |
| 2018 Q4 | -0.00 CAD | 0.0% |
| 2018 FY | - CAD | 0.0% |
| 2017 Q4 | -0.01 CAD | 0.0% |